Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
2
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
0 competitors in Lentigo Maligna Melanoma (Head or Neck)
View Full LandscapeTarget Indication
Lentigo Maligna Melanoma (Head or Neck)
Clinical Trial
NCT01720407Last updated: 9/30/2026
No patent data available. Pre-approval drugs may not have Orange Book listings.
Zyclara
Zyclara is indicated for the topical treatment of clinically typical, non-hyperkeratotic, non-hypertrophic, visible or palpable actinic keratosis of the full face or balding scalp in immunocompetent adults when other topical treatment options are contraindicated or less appropriate.
View on EMAZartra
Imiquimod cream is indicated for the topical treatment of external genital and perianal warts (condyloma acuminata) in adult patients.
View on EMA